Work

UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group.

Year: 1999

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PubMed

Authors: Y Hata, J Uchino, K Asaishi, Y Kubo, M Mito, T Tanabe, M Ogita, K Hirata

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W145981643

FWCI: 0.126

Cites:

Cited by: 2

Related to: 10